TSG-6 as a biomarker to predict efficacy of human mesenchymal stem/progenitor cells (hMSCs) in modulating sterile inflammation in vivo
dc.creator | Ryang Hwa Lee | |
dc.creator | Ji Min Yu | |
dc.creator | Andrea M. Foskett | |
dc.creator | Grant Peltier | |
dc.creator | John C. Reneau | |
dc.creator | Nikolay Bazhanov | |
dc.creator | Joo Youn Oh | |
dc.creator | Darwin J. Prockop | |
dc.date.accessioned | 2019-10-09T21:00:21Z | |
dc.date.available | 2019-10-09T21:00:21Z | |
dc.date.issued | 2014 | |
dc.identifier.issn | 0027-8424 | |
dc.identifier.issn | 0744-2831 | |
dc.identifier.issn | 1091-6490 | |
dc.identifier.uri | https://hdl.handle.net/1969.1/182159 | |
dc.format.extent | 1 | en |
dc.publisher | Proceedings of the National Academy of Sciences of the United States of America | |
dc.relation.ispartof | 1foldr Import 2019-10-08 Batch 8 | en |
dc.relation.uri | 10.1073/pnas.1416121111 | en |
dc.title | TSG-6 as a biomarker to predict efficacy of human mesenchymal stem/progenitor cells (hMSCs) in modulating sterile inflammation in vivo | en |